References
- Torabinejad M, Hong CU, McDonald F, Pitt Ford TR. Physical and chemical properties of a new root-end filling material. J Endod 1995;21:349-353 https://doi.org/10.1016/S0099-2399(06)80967-2
- Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to Mineral Trioxide Aggregate. J Endod 1998;24:543-547 https://doi.org/10.1016/S0099-2399(98)80074-5
- Robert HW, Toth JM, Berzins DW, Charlton DG. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature. Dent Mater 2008;24:149-164 https://doi.org/10.1016/j.dental.2007.04.007
- Zhu Q, Haglund R, Safavi KE, Spangberg LSW. Adhesion of human osteoblasts on root-end filling materials. J Endod 2000;26:404-406 https://doi.org/10.1097/00004770-200007000-00006
- Torabinejad M, Hong CU, Pitt Ford TR, Kettering JD. Cytotoxicity of four root-end filling materials. J Endod 1995;21:489-492 https://doi.org/10.1016/S0099-2399(06)80518-2
- Pelliccioni GA, Ciapetti G, Cenni E, Granchi D, Nanni M, Pagani S, Giunti A. Evaluation of osteoblast-like cell response to ProRoot MTA cement. J Mat Sci 2004;15:167-173
- Yavuzyilmaz E, Yamalik N, Bulut S, Ozen S, Ersoy F, Saatci U. The gingival crevicular fluid interleukin-1beta and tumor necrosis factor-a levels in patients with rapidly progressive periodontitis. Aust Dent J 1995;40:46-49 https://doi.org/10.1111/j.1834-7819.1995.tb05614.x
- Tsai CC, Hou YP, Chen CC. Levels of interleukin-1beta and interleukin-8 in gingival crevicular fluid in adult periodontitis. J Periodontol 1995;66:852-859 https://doi.org/10.1902/jop.1995.66.10.852
- Ishihara Y, Kuroyagani T, Shirozi N, Yamagishi E, Ohguchi M, Koide M, Ueda N, Amano K, Noguchi T. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res 1997;32:524-529 https://doi.org/10.1111/j.1600-0765.1997.tb00568.x
- Giannopoulou C, Kama JJ, Mombelli A. Effect of inflammation, smoking, and stress on gingival, crevicular fluid cytokine level. Journal of Clinical Periodontology 2003;30:145-153 https://doi.org/10.1034/j.1600-051X.2003.300201.x
- Barrieshi-Nusair K, Qudeimat MA. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth. J Endod 2006;32:731-735 https://doi.org/10.1016/j.joen.2005.12.008
- Cory AH, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991;3:207-212
- Nakayama A, Ogiso B, Tanabe N, Takeichi O, Matsuzaka K, Inoue T. Behaviour of bone marrow osteoblasts-like cells on mineral trioxide aggregate: morphology and expression of type 1 collagen and bone-related protein mRNAs. Int Endodont J 2005;38:203-210 https://doi.org/10.1111/j.1365-2591.2004.00917.x
- Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand : Modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275:768-775 https://doi.org/10.1006/bbrc.2000.3379
- Hofbaur LC, Heufelder AE. Role of receptor activator of nuclear factor-kB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-253 https://doi.org/10.1007/s001090100226
- Siggelkow H, Eidner T, Lehmann G, Viereck V, Raddatz D, Munzel U, Hein G, Hufner M. Cytokine, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone disease. J Bone Miner Res 2003;18:529-538 https://doi.org/10.1359/jbmr.2003.18.3.529
- Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 2001;20:1271-1280 https://doi.org/10.1093/emboj/20.6.1271
- Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post menopausal osteoporosis. J Dent Res 2006;85:596-607 https://doi.org/10.1177/154405910608500704
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342 https://doi.org/10.1038/nature01658
- Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(Suppl):1569-1576 https://doi.org/10.1902/jop.2008.080233
- Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytoline Growth Factor Rev 2002;13:357-368 https://doi.org/10.1016/S1359-6101(02)00027-8
- Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucan LA, Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996;64:3231-3235